IFPA Releases New Psoriatic Care Roadmap and Action Playbook for Asia
IFPA has released the Psoriatic Care Roadmap and Action Playbook for Asia. The new resources are guides featuring advocacy demands and practical strategies that aim to elevate psoriatic care across the continent. The roadmap addresses four crucial themes that emerged from the IFPA Forum Asia 2023, held in Singapore: 1. Access to Care for People with Psoriatic Disease 2. Addressing and Managing Comorbidities […]
First Patient Dosed in Artax’s Phase 2a Psoriasis Trial Evaluating AX-158
The first patient has been dosed in the Artax’s Phase 2a trial evaluating the safety and biomarker responses of AX-158 in a first proof of mechanism trial in psoriasis. AX-158 has potential to be the first immunomodulator in the Nck blocker class, the Company states. Safety and efficacy results are expected in second half of 2024. “The new Nck […]
Psoriasis Linked to Poor Sleep Quality
Despite a widely reported prevalence of sleep disturbances among psoriasis patients, discrepant results exist regarding the quantitative effect of psoriasis on sleep. Now, a new study suggests that the jury is in. Psoriasis is associated with poor sleep quality and higher risk for sleep disturbances, especially among patients with psoriatic arthritis, severe psoriasis, shorter duration of […]
Better Together: Tapinarof Cream, 1% Plus Biologics Show Promise in Psoriasis
More than half of adult psoriasis patients on biologics hit the National Psoriasis Foundation treat-to-target goal of 1% body surface area (BSA) or less involvement within three months of adding Tapinarof cream, 1% (Vtama, Dermavant).
AI Capabilities, Concerns
Clifford Perlis, MD, discusses artificial intelligence in dermatology, including current capabilities and concerns as well as future opportunities. Clifford Perlis, MD, co-founder and former Chief Medical Officer of Belle.ai, Board-Certified Dermatologist, Keystone Dermatology Partners, King of Prussia, Pa. “For so many years, we’ve talked about [AI] like it’s coming. It’s just down the road. It’s […]
New Treatments for Psoriasis
Dr. Alice Gottlieb discusses the science behind recently approved therapies for psoriasis, including their mechanisms of action and efficacy. Alice Gottlieb, MD, PhD, Medical Director of Dermatology, Mount Sinai in New York City, New York. “I presented a summary of what is known about the interleukin (IL)-17 and -23 blockers, and introduced bimekizumab (not yet […]
The Future of Topical Therapy for Psoriasis
In the third and final video in this educational series, Dr. Linda Stein Gold reviews and discusses the clinical research of two new molecules for treatment of mild-to-moderate psoriasis. About the Series This 3-part video educational program examines the current and future treatment landscape for mild to moderate psoriasis, including an examination of disease pathogenesis […]
Tips for Treating Women With Psoriasis
Dr. Jenny Murase discusses treatment options and management for patients with psoriasis who are or may become pregnant. Jenny Murase, MD, is Associate Clinical Professor of Dermatology at the University of California, San Francisco, and Director of Medical Consultative Dermatology, Palo Alto Medical Foundation, Mountain View, California. “As we know, psoriasis is a chronic inflammatory […]
Itch’s impact on people with psoriasis
With Aaron Secrest, MD, PhD To better understand how itch affects psoriasis patients, Dr. Secrest and colleagues conducted a study with five focus groups and 10 semi-structured interviews asking pointed questions about itch. The study enrolled 25 people diagnosed with at least moderate plaque psoriasis and 11 family members. “Every dermatologist knows that psoriasis is […]